Literature DB >> 7271453

The influence of haemoperfusion on haemostasis and cellular constituents of the blood in the treatment of intoxications: a comparative study of three types of columns (Haemocol, Amberlite XAD-4, Gambro Adsorba 300 C).

B Sangster, A N van Heijst, J J Sixma.   

Abstract

The influence of haemoperfusion on blood-coagulation and cellular constituents of the blood was studied in three groups of patients. In four patients haemoperfusion was performed using a column containing acrylic-hydrogel coated activated charcoal (Haemocol), in five patients with a column containing uncoated XAD-4 nonionic polystyrene resin (Amberlite) and in five patients with a column containing cellulose coated activated charcoal (Gambro Adsorba 300 C). Perfusion was performed during 4 h with a flow of 300 ml/min. Before the start, 2 h after the start, at the end and 2 h after the end of the perfusion the haemoglobin concentration, haematocrit, leucocyte number, differential white cell count, thrombocyte number and heparin concentration were measured. Before the start and 2 h after the end prothrombin time, thrombin time, partial thromboplastin time, reptilase time, fibrinogen, prothrombin, factors V, VII, X, antithrombin III, bleeding time (Ivy), ethanol gelation test, fibrin split products and plasminogen were measured. The following conclusions can be drawn: haemoperfusion per se causes haemodilution; polystyrene resin causes in some patients a temporary reduction of the leucocyte number during haemoperfusion; polystyrene resin causes a significant reduction of thrombocyte number compared to coated activated charcoal; polystyrene resin and to a lesser extent acrylic-hydrogel-coated activated charcoal causes in some patients a prolongation of bleeding time probably by inducing alteration of thrombocyte function caused by release; polystyrene resin and probably also acrylic-hydrogel-coated activated charcoal causes an increased fibrinolytic activity without signs of disseminated intravascular coagulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7271453     DOI: 10.1007/BF00332393

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  7 in total

1.  [The pros and cons of haemoperfusion (author's transl)].

Authors:  H Hennemann; I E Richter; D Brunswig; A Röckel; J Kult; W Gattenlöhner; A Heidland
Journal:  Klin Wochenschr       Date:  1977-06-01

2.  A simple technique for the measurement of plasma heparin concentration during anticoagulant therapy.

Authors:  V J Marder
Journal:  Thromb Diath Haemorrh       Date:  1970-10-31

3.  [Disorders of blood coagulatiion during haemoperfusion (author's transl)].

Authors:  H Niessner; M Pichler
Journal:  Wien Klin Wochenschr       Date:  1977-05-13       Impact factor: 1.704

4.  Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease.

Authors:  C Beurling-Harbury; C A Galvan
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

5.  Salicylate removal by charcoal haemoperfusion in experimental intoxication in dogs:an assessment of efficacy and safety.

Authors:  C H Brookings; J D Ramsey
Journal:  Arch Toxicol       Date:  1975-11-20       Impact factor: 5.153

6.  The safety assessment in the dog of a charcoal haemoperfusion column.

Authors:  J C Kolthammer; P A Watson; S Lang; J Fennimore
Journal:  Clin Sci Mol Med       Date:  1976-12

7.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245

  7 in total
  4 in total

1.  Continuous plasma perfusion of dual cartridges in series: rationale and early clinical experience.

Authors:  Liang Sun; Peng-Bo Yan; Yu-Hua Zhang; Lu-Qing Wei; Guo-Qiang Li
Journal:  J Artif Organs       Date:  2016-07-13       Impact factor: 1.731

Review 2.  Artificial livers--what's keeping them?

Authors:  E Davies; H J Hodgson
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

3.  The influence of haemoperfusion on white cells, immunoglobulin concentrations and the complement system in the treatment of intoxications.

Authors:  J H Rommes; B Sangster; F H Gmelig Meyling; M R Daha; A N van Heijst
Journal:  Arch Toxicol       Date:  1983-02       Impact factor: 5.153

4.  Biocompatibility of haemoperfusion.

Authors:  J H Rommes; B Sangster; L Berrens; C Borst; A N van Heijst
Journal:  Arch Toxicol       Date:  1986-02       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.